Skeletal muscle uncoupling protein 3 (UCP3): Mitochondrial uncoupling protein in search of a function

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 5, Issue 3, 2002, Pages 265-270

  Schrauwen, Patrick ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; DNA; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3; CARRIER PROTEIN; FATTY ACID; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 3; UNCOUPLING PROTEIN;

BODY WEIGHT; CACHEXIA; CANCER; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY ACID TRANSPORT; GLUCOSE METABOLISM; HUMAN; METABOLIC RATE; MITOCHONDRIAL RESPIRATION; MUSCLE MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REVIEW; SKELETAL MUSCLE; METABOLISM; MITOCHONDRION; PHYSIOLOGY; UPREGULATION;

BODY WEIGHT; CARRIER PROTEINS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FATTY ACIDS; HUMANS; ION CHANNELS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; OBESITY; REACTIVE OXYGEN SPECIES; UNCOUPLING AGENTS; UP-REGULATION;

EID: 0036584955     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200205000-00005     Document Type: Review

References (47)

1. Mitchell P. Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. Biol Rev Camb Philos Soc 1966; 41:445-502.
2. Rolfe DFS, Brown GC. Cellular energy utilization and molecular origin of standard metabolic rate in mammals. Physiol Rev 1997; 77:731-758.
3. Nicholls D, Bernson V, Heaton G. The identification of the component in the inner membrane responsible for regulating energy dissipation. In: Effectors of thermogenesis. Girardier L, Seydoux J (editors). Basel: Birkhauser Verlag; 1978. pp. 89-93.
4. Klingenberg M, Echtay KS, Bienengraeber M, et al. Structure-function relationship in UCP1. Int J Obes Relat Metab Disord 1999; 23 (Suppl. 6):S24-S29.
5. Jezek P, Engstová H, Zácková M, et al. Fatty acid cycling mechanism and mitochondrial uncoupling proteins. Biochim Biophys Acta 1998; 1365:319-327.
6. Fleury C, Neverova M, Collins S, et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997; 15:269-273.
7. Boss O, Samec S, Paoloni-Giacobino A, et al. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 1997; 408:39-42.
8. Gong D-W, He Y, Karas M, Reitman M. Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, β3-adrenergic agonists, and leptin. J Biol Chem 1997; 272:24129-24132.
9. Vidal-Puig AJ, Grujic D, Zhang CY, et al. Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 2000; 275:16258-16266. A report on the creation of UCP3 knockout mice. The mitochondria of these mice indeed showed improved coupling, but the major finding is that these mice have no apparent phenotype, i.e. are not obese.
10. Clapham JC, Arch JR, Chapman H, et al. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 2000; 406:415-418. Mice overexpressing human UCP3 were created. These mice are hyperphagic but lean, indicating an increased metabolic rate. UCP3 overexpression improved glucose handling, suggesting a role for UCP3 in glucose metabolism.
11. Cline GW, Vidal-Puig AJ, Dufour S, et al. In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism. J Biol Chem 2001; 276:20240-20244. Further characterization of the UCP3 knockout mice previously described in Ref. [9]. In-vivo uncoupling was determined by measuring the rate of ATP synthesis and TCA cycle flux using NMR. The results show the first evidence for in-vivo uncoupling activity of UCP3 in skeletal muscle.
12. Bouchard C, Pérusse L, Chagnon YC, et al. Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum Mol Genet 1997; 6:1887-1889.
13. Dalgaard LT, Pedersen O. Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type II diabetes. Diabetologia 2001; 44:946-965.
14. Ricquier D, Bouillaud F. The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem J 2000; 345:161-179. An excellent and extensive review of the current state of knowledge of mitochondrial uncoupling proteins.
15. Schrauwen P, Xia J, Bogardus C, et al. Skeletal muscle UCP3 expression is a determinant of energy expenditure in Pima Indians. Diabetes 1999; 48:146-149.
16. Schrauwen P, Troost FJ, Xia J, et al. Skeletal muscle UCP2 and UCP3 expression in trained and untrained male subjects. Int J Obes Relat Metab Disord 1999; 23:966-972.
17. Schrauwen P, Schaart G, Saris WHM, et al. The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in type II diabetic subjects. Diabetologia 2000; 43:1408-1416. The UCP3 protein content was reduced after weight reduction in type 2 diabetic subjects. The degree of reduction was related to the degree of weight loss, with the subjects that lost most weight having the least change in UCP3 protein. The results suggest that high levels of UCP3 protein might facilitate weight loss.
18. Simonyan RA, Jimenez M, Ceddia RB, et al. Cold-induced changes in the energy coupling and the UCP3 level in rodent skeletal muscles. Biochim Biophys Acta 2001; 1505:271-279.
19. Sanchís D, Busquets S, Alvarez B, et al. Skeletal muscle UCP2 and UCP3 gene expression in a rat cancer cachexia model. FEBS Lett 1998; 436:415-418.
20. de Lange P, Lanni A, Beneduce L, et al. Uncoupling protein-3 is a molecular determinant for the regulation of resting metabolic rate by thyroid hormone. Endocrinology 2001; 142:3414-3420. The time course of resting metabolic rate and UCP3 protein content in response to triiodothyronine injection in rats showed striking similarities, with highest resting metabolic rate and UCP3 protein 65 h after injection. The study suggests that UCP3 might be involved in thyroid-induced thermogenesis.
21. Lebon V, Dufour S, Petersen KF, et al. Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest 2001; 108:733-737. Human subjects were treated for 3 days with triiodothyronine hormone, and mitochondrial coupling was measured using NMR. Triiodothyronine treatment improved in-vivo mitochondrial coupling in human skeletal muscle, possibly as a result of increased UCP3 (not measured).
22. Gong DW, Monemdjou S, Gavrilova O, et al. Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem 2000; 275:16251-16257. Detailed phenotypical characterization of UCP3 knockout mice. The results indicate that UCP3 is responsible for a great part of the proton leak in muscle, but that the lack of UCP3 does not affect body weight, body temperature or oxidative capacity in response to fasting and thyroid hormone.
23. Millet L, Vidal H, Andreelli F, et al. Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest 1997; 100:2665-2670.
24. Schrauwen P, Westerterp-Plantenga MS, Kornips E, et al. The effect of mild cold exposure on UCP3 mRNA expression and UCP3 protein content in humans. Int J Obes Relat Metab Disord 2002; in press.
25. Skulachev VP. Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta 1998; 1363:100-124.
26. Kerner J, Turkaly PJ, Minkler PE, Hoppel CL. Aging skeletal muscle mitochondria in the rat: decreased uncoupling protein-3 content. Am J Physiol Endocrinol Metab 2001; 281:E1054-E1062. Aging decreases UCP3 content and state 4 respiration in rats.
27. Pilegaard H, Ordway GA, Saltin B, Neufer PD. Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol Endocrinol Metab 2000; 279:E806-E814.
28. Schrauwen P, Hesselink MKC, Vaartjes I, et al. The effect of acute exercise on uncoupling protein 3 is a fat metabolism mediated effect. Am J Physiol Endocrinol Metab 2002; 282:E11-E17. Acute exercise increased UCP3 mRNA expression 4 hours post-exercise in untrained human subjects. The increase was prevented by administration of glucose drinks, suggesting that the exercise-induced increase in UCP3 is related to changes in free fatty acids and/or fat oxidation.
29. Maziere C, Conte MA, Degonville J, et al. Cellular enrichment with polyunsaturated fatty acids induces an oxidative stress and activates the transcription factors AP1 and NFkappaB. Biochem Biophys Res Commun 1999; 265:116-122.
30. Bashan N, Burdett E, Guma A, et al. Mechanisms of adaptation of glucose transporters to changes in the oxidative chain of muscle and fat cells. Am J Physiol 1993; 264:C430-C440.
31. Huppertz C, Fischer BM, Kim YB, et al. Uncoupling protein 3 (UCP3) stimulates glucose uptake in muscle cells through a phosphoinositide 3-kinase-dependent mechanism. J Biol Chem 2001; 276:12520-12529. The overexpression of human UCP3 in L6 myotubes increases glucose uptake. The effect could be prevented by wortmannin, suggesting that UCP3 increases glucose uptake via the phosphatidylinositol 3 kinase-dependent pathway.
32. Pedersen SB, Lund S, Buhl ES, Richelsen B. Insulin and contraction directly stimulate UCP2 and UCP3 mRNA expression in rat skeletal muscle in vitro. Biochem Biophys Res Commun 2001; 283:19-25. The first report showing that insulin is able to induce UCP3 expression rapidly in rat skeletal muscle in vitro.
33. Schrauwen P, Xia J, Walder K, et al. A novel polymorphism in the proximal UCP3 promoter region: effect on skeletal muscle UCP3 mRNA expression and obesity in male non-diabetic Pima Indians. Int J Obes Relat Metab Disord 1999; 23:1242-1245.
34. Meirhaeghe A, Amouyel P, Helbecque N, et al. An uncoupling protein 3 gene polymorphism associated with a lower risk of developing type II diabetes and with atherogenic lipid profile in a French cohort. Diabetologia 2000; 43:1424-1428. An association study, examining a C to T substitution in the promotor of UCP3. The T-allele frequency, previously associated with increased UCP3 mRNA expression, was lower in diabetic subjects.
35. Schrauwen P, Hesselink MKC, Blaak EE, et al. Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes mellitus. Diabetes 2001; 50:2870-2873. UCP3 protein content was twofold lower in patients with type 2 diabetes compared with controls, independent of body mass index.
36. Hesselink MKC, Keizer HA, Borghouts LB, et al. Protein expression of UCP3 differs between human type 1, type 2a and type 2b fibers. FASEB J 2001; 15:1071-1073. Immunofluoresence was combined with conventional fibre typing to study fibre type and UCP3 expression in human vastus lateralis muscle concurrently. UCP3 protein expression was most abundant in type 2b fibres, less in type 2a fibres, and only moderately expressed in type 1 fibres.
37. Winder WW. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol 2001; 91:1017-1028. An excellent review of the suggested mechanisms and putative functions of AMPK.
38. Dulloo AG, Samec S. Uncoupling proteins: their roles in adaptive thermogenesis and substrate metabolism reconsidered. Br J Nutr 2001; 86:123-139. A recent review on the putative roles of UCP2 and UCP3. It was concluded that UCP3 is involved in the flux of lipid substrates across the mitochondria.
39. Argyropoulos G, Brown AM, Willi SM, et al. Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest 1998; 102:1345-1351.
40. Bezaire V, Hofmann W, Kramer JK, et al. Effects of fasting on muscle mitochondrial energetics and fatty acid metabolism in Ucp3(-/-) and wild-type mice. Am J Physiol Endocrinol Metab 2001; 281:E975-E982. UCP3 knockout mice showed reduced resting respiratory quotient, implying a role for UCP3 in fatty acid metabolism. State 4 respiration was not altered in UCP3 knockout mice.
41. Schrauwen P, Hoppeler H, Billeter R, et al. Fiber type dependent upregulation of human skeletal muscle UCP2 and UCP3 mRNA expression by high-fat diet. Int J Obes Relat Metab Disord 2001; 25:449-456. In human subjects, 4 weeks of high-fat diet increased UCP3 mRNA expression. The increase was most pronounced in subjects with a high percentage of type IIa muscle fibres.
42. Busquets S, Carbo N, Almendro V, et al. Hyperlipemia: a role in regulating UCP3 gene expression in skeletal muscle during cancer cachexia? FEBS Lett 2001; 505:255-258. This study indicates that the increased expression of UCP3 in the cancer cachexia state in rats is related to high plasma free fatty acid levels. The administration of nicotonic acid, to lower plasma free fatty acid levels, reduced UCP3 expression.
43. Schrauwen P, Saris WH, Hesselink MK. An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix. FASEB J 2001; 15:2497-2502. A critical review and analysis of the available human UCP3 data. On the basis of the present data it is suggested that UCP3 might act as a transporter of fatty acid anions out of the mitochondrial matrix, thereby protecting mitochondria against accumulations of fatty acids.
44. Himms-Hagen J, Harper ME. Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. Exp Biol Med (Maywood) 2001; 226:78-84. A hypothesis on the putative function of UCP3 as a transporter of fatty acid anions out of the mitochondrial matrix. It proposes that excess acyl-coenzyme A within the mitochondria is hydrolysed by a mitochondrial acyl-coenzyme A thioesterase, yielding fatty acid anion and the sulfhydryl group of coenzyme A.
45. Moore GB, Himms-Hagen J, Harper ME, Clapham JC. Overexpression of UCP-3 in skeletal muscle of mice results in increased expression of mitochondrial thioesterase mRNA. Biochem Biophys Res Commun 2001; 283:785-790. This study provides evidence for the hypothesis in Ref [44]. Mice overexpressing UCP3 have increased thioesterase mRNA expression, to make fatty acid anions available for UCP3.
46. Clapham JC, Coulthard VH, Moore GB. Concordant mRNA expression of UCP-3, but not UCP-2, with mitochondrial thioesterase-1 in brown adipose tissue and skeletal muscle in db/db diabetic mice. Biochem Biophys Res Commun 2001; 287:1058-1062. See Ref. [44]. Thioesterase expression was related to UCP3 expression.
47. Cabrero A, Alegret M, Sanchez R, et al. Uncoupling protein-3 mRNA upregulation in C2C12 myotubes after etomoxir treatment. Biochim Biophys Acta 2001; 1532:195-202. Etomoxir, a blocker of carnitine palmitoyl transferase 1, which thereby prevented the entry of fatty acids into the mitochondria, resulted in increased UCP3 expression. This fits with the hypothesis in Ref. [43], but not with the hypothesis in Ref. [44].